Prim-O-glucosylcimifugin ameliorates rheumatoid arthritis by targeting GBP5 to suppress pyroptosis and inhibit synovial cell proliferation

Biochemical Pharmacology 2026

View at publisher
Authors: Yuxuan Wang, Wei Guan, Shuping Wang, Yu Bi, Jinling Zhang, Zhichao Hao, Zhenqiang Liu, Mengmeng Li, Shu Liu, Qingshan Chen, Li Zhang, Haixue Kuang
+2 more Lili Huang, Y Liu
DOI: 10.1016/j.bcp.2026.118100
Cited by: 1
References: 54

Fields of Study & Subjects

Inflammasome and immune disorders Osteomyelitis and Bone Disorders Research NF-κB Signaling Pathways

Publication details

Journal / source
Biochemical Pharmacology
Publisher
Elsevier BV
Volume
251
Issue
Pt 1
Pages
118100–118100
Publication date
24 May 2026
Language
EN